Ventas, Inc. (VTR): analysis and signal as of September 4, 2026

Published on September 6, 2026 at 07:03 · Updated on September 6, 2026 at 07:03 · by Aurélien Ambert, QDNA

Exchange : NYSE · Sector : Finance

In short

The signal is weak with a vote of 3/3 and no score. The main reason is the pressure on refinancing costs in the healthcare sector, without a catalyst for lower long-term rates.

Current signal: weak (vote 3/3)
Deterministic score: -0.5 → signal expected by the scale : weak (September 10, 2026)
Layers: fundamentals : neutral, price : neutral, risks : neutral

Triggered rules

Rule	Weight
penalizes an asset whose net debt/EBITDA exceeds the threshold, and the use of leverage (margin/lombard)	-2.5
favors (GARP) a stock whose PEG is below 1, growth not yet paid for	+1.5
penalizes direct holding of US securities in a CTO (US estate tax at death), favors a UCITS ETF domiciled in IE	-1.0
favors a "fast grower" profile, high and durable earnings growth (> 20 %), to be cross-checked against the PEG	+1.0
moderately favors a positive 12-1 month momentum (tailwind), BUT guardrail: costly rotation, long-term reversal, momentum crashes, a conviction signal, not a rotation trigger	+0.5

Thesis

Ventas is a high-credit-quality healthcare REIT, with a sector competitive advantage in senior housing and MOB. The current macroeconomic configuration, with a stable Fed at 3,63 %, a 10-2 US slope at +0,43 pt and US inflation at 3,5 % off target, maintains pressure on refinancing costs in the sector, without a catalyst for lower long-term rates. The recent technical flow shows a fragile shift in retail flows, from night flow to day flow over 6 months. The zone between MM50 and MM200 indicates consolidation without a directional impulse. The 'neutre' verdict from the three layers is consistent with observing a catalyst, such as the BCE on 10/09 or a Fed turn, to justify a directional stance.

Bull case

The defensive healthcare sector benefits from the current macroeconomic regime. US GDPNow at 4,7 % supports occupancy for MOB operators and senior housing. The dividend of about 3 % with aristocrat status and the high credit rating assigned by the three agencies offer protection in case of stress. These elements support the thesis of credit quality and stability of the healthcare REIT.

Bear case

VTR is rate-sensitive, with a 10-2 US slope at +0,43 pt and a stable Fed at 3,63 %, without a near-term decline outlook. The defensive asset is less suited to the bullish EXPANSION regime (0,58), which pushes toward high-momentum risk assets. The shift from night flow to day flow over 6 months signals downside elasticity if retail flow withdraws. These factors weigh on the valuation of the stock.

Scenarios

The bullish scenario has a 25 % probability, with an accommodative Fed turn and compression of REIT rate spreads, for +15-20 %. The central scenario has a 50 % probability, with consolidation around the current price, a gross yield of ~3 % and a neutral macroeconomic drift. The bearish scenario has a 25 % probability, with Fed tightening, a further steepening of +0,20 pt, for -15 to -20 %.

Risks

The main risk comes from rate sensitivity, with a 10-2 US slope at +0,43 pt and a stable Fed at 3,63 %, which weighs on refinancing costs in the healthcare sector. VTR's defensive asset is less suited to the bullish EXPANSION regime (0,58). The shift from night flow to day flow over 6 months can amplify a decline if retail flow withdraws.

Market positioning (short sellers)

Short interest / shares outstanding: 4.64 %
Days to cover: 7.58
Settlement date: 2026-08-14
Source: FINRA (disseminated on 2026-08-26)

Market information published by FINRA (consolidated short interest, all venues), no directional comment.

Signal history (last 12 months)

Date	Signal	New fact
September 4, 2026	weak (3/3)	The content remains unchanged. The analysis is a personal production, not advice.

Frequently asked questions

Why is the signal weak?

The signal is weak with a vote of 3/3 and no score. Pressure on refinancing costs in the healthcare sector persists, because the Fed remains at 3,63 %, the 10-2 US slope is at +0,43 pt and US inflation is at 3,5 %. The neutre verdict from the three layers remains consistent with observing a catalyst, such as a Fed turn.

What is the main bullish argument?

What is the main bearish argument?

Sources

The official filings below are the issuer's own, matched to this stock by its identifier (LEI, CIK or ISIN). The figures quoted above come from an automated arbitration: they have not been re-checked one by one.

July 30, 2026 — 10-Q (SEC · 10-Q)
July 29, 2026 — 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits (SEC · 8-K)
June 15, 2026 — 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; 8.01 Oth… (SEC · 8-K)
May 15, 2026 — 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; 5.07 Sub… (SEC · 8-K)
April 28, 2026 — 10-Q (SEC · 10-Q)

Automated AI analysis: limitations and transparency

This content is an automated analysis produced using artificial intelligence. Personal analysis for information purposes — no personalised investment advice. MMR content consists of general research. It does not take account of your financial circumstances, objectives or risk tolerance. Data, analyses and results, including those produced using artificial intelligence, may contain errors, be incomplete or become outdated. No return or outcome is guaranteed. All investments carry a risk of partial or total loss of capital. Past performance and simulations do not predict future results. Before making any decision, check information against original sources and, where necessary, consult an authorised professional. You remain responsible for your investment decisions. This notice does not exclude or limit any liability that cannot legally be excluded or limited.
Tool and analysis: QDNA, Aurélien Ambert.
Analysis (arbitration) completed on September 4, 2026; this page was completed on September 6, 2026 at 07:03 (UTC).
Interests: no position in the stock analysed (VTR) is recorded in the data consulted on September 12, 2026 (UTC). This does not confirm the absence of holdings or other interests. The situation at the analysis publication date has not been reconstructed.
This declaration covers only recorded positions in this stock; it is not an exhaustive verification of other interests or remuneration.
Methodology: analysis chain, score formula and scale described on the public methodology page.
Analysis horizon: 2035.